Closed

NP39726 Generic and Biosimilar Cancer Medicines

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

Value
£197,026,942
Published
27 Jul 2026
Deadline
26 Aug 2026
Procedure
Open procedure
Category
33600000 — Pharmaceutical products
Location
UKM
Notice reference
070486-2026

Requirements summary

The Common Services Agency is procuring Generic and Biosimilar Cancer Medicines for NHS Scotland through an open tender procedure, with a total estimated value of GBP 197,026,942. The contract includes multiple lots with specific cancer medicines to be supplied over a twenty-four month period, with the possibility of extension.

Key requirements

  • Supply of Generic and Biosimilar Cancer Medicines including Bendamustine, Capecitabine, Cisplatin, Cyclophosphamide, and Cytarabine.
  • Single supplier framework agreements for each lot.
  • Contract duration of twenty-four months with the option for a twenty-four month extension.
  • Mandatory community benefits provision required from bidders.
  • Potential suppliers must agree to connect with NHS Scotland's Community Benefits Gateway.

Similar open notices

NP39726 Generic and Biosimilar Cancer Medicines — The C… | ProposAI